98 related articles for article (PubMed ID: 8278006)
21. Parasite-specific IgG response and peripheral blood eosinophil count following albendazole treatment for presumed chronic strongyloidiasis.
Karunajeewa H; Kelly H; Leslie D; Leydon J; Saykao P; Biggs BA
J Travel Med; 2006; 13(2):84-91. PubMed ID: 16553594
[TBL] [Abstract][Full Text] [Related]
22. Current progress toward vaccine and passive immunization approaches for Strongyloides spp.
Levenhagen MA; Conte H; Costa-Cruz JM
Immunol Lett; 2016 Dec; 180():17-23. PubMed ID: 27769813
[TBL] [Abstract][Full Text] [Related]
23. Strongyloides stercoralis: identification of antigens in natural human infections from endemic areas of the United States.
Siddiqui AA; Koenig NM; Sinensky M; Berk SL
Parasitol Res; 1997; 83(7):655-8. PubMed ID: 9272553
[TBL] [Abstract][Full Text] [Related]
24. Identification of antigenic proteins in Strongyloides stercoralis by proteomic analysis.
Rodpai R; Intapan PM; Thanchomnang T; Sanpool O; Janwan P; Laummaunwai P; Wongkham C; Insawang T; Maleewong W
Parasitol Res; 2017 Jun; 116(6):1687-1693. PubMed ID: 28455628
[TBL] [Abstract][Full Text] [Related]
25. Strongyloides stercoralis host-adapted third-stage larvae are the target of eosinophil-associated immune-mediated killing in mice.
Brigandi RA; Rotman HL; Leon O; Nolan TJ; Schad GA; Abraham D
J Parasitol; 1998 Apr; 84(2):440-5. PubMed ID: 9576523
[TBL] [Abstract][Full Text] [Related]
26. Short epitope-based synthetic peptides for serodiagnosis of human strongyloidiasis.
Feliciano ND; Ribeiro VS; Gonzaga HT; Santos FA; Fujimura PT; Goulart LR; Costa-Cruz JM
Immunol Lett; 2016 Apr; 172():89-93. PubMed ID: 26956434
[TBL] [Abstract][Full Text] [Related]
27. Immunoaffinity-isolated antigens induce protective immunity against larval Strongyloides stercoralis in mice.
Herbert DR; Nolan TJ; Schad GA; Lustigman S; Abraham D
Exp Parasitol; 2002 Feb; 100(2):112-20. PubMed ID: 12054701
[TBL] [Abstract][Full Text] [Related]
28. Parasitological and immunological diagnosis of Strongyloides stercoralis in patients with gastrointestinal cancer.
Machado ER; Teixeira EM; Gonçalves-Pires Mdo R; Loureiro ZM; Araújo RA; Costa-Cruz JM
Scand J Infect Dis; 2008; 40(2):154-8. PubMed ID: 17852953
[TBL] [Abstract][Full Text] [Related]
29. Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis.
Satoh M; Toma H; Sugahara K; Etoh K; Shiroma Y; Kiyuna S; Takara M; Matsuoka M; Yamaguchi K; Nakada K; Fujita K; Kojima S; Hori E; Tanaka Y; Kamihira S; Sato Y; Watanabe T
Oncogene; 2002 Apr; 21(16):2466-75. PubMed ID: 11971181
[TBL] [Abstract][Full Text] [Related]
30. Clinical infection with Strongyloides sterocoralis following etanercept use for rheumatoid arthritis.
Boatright MD; Wang BW
Arthritis Rheum; 2005 Apr; 52(4):1336-7. PubMed ID: 15818680
[No Abstract] [Full Text] [Related]
31. Epidemiologic study of the association between human T-cell lymphotropic virus type 1 and Strongyloides stercoralis infection in female blood donors (Guadeloupe, French West Indies).
Courouble G; Rouet F; Herrmann-Storck C; Nicolas M; Candolfi E; Deloumeaux J; Carme B
West Indian Med J; 2004 Jan; 53(1):3-6. PubMed ID: 15114885
[TBL] [Abstract][Full Text] [Related]
32. Improved antigens for IgG-ELISA diagnosis of strongyloidiasis.
Dekumyoy P; Somtana K; Jantanawiwat P; Nuamtanong S; Sa-nguankiat S; Nuchfaong S; Janyapoon K; Chindanond D
Southeast Asian J Trop Med Public Health; 2002; 33 Suppl 3():53-9. PubMed ID: 12971475
[TBL] [Abstract][Full Text] [Related]
33. Human immunoglobulin G mediates protective immunity and identifies protective antigens against larval Strongyloides stercoralis in mice.
Kerepesi LA; Nolan TJ; Schad GA; Lustigman S; Herbert DR; Keiser PB; Nutman TB; Krolewiecki AJ; Abraham D
J Infect Dis; 2004 Apr; 189(7):1282-90. PubMed ID: 15031798
[TBL] [Abstract][Full Text] [Related]
34. Immune reconstitution syndrome to Strongyloides stercoralis syndrome: authors' response.
McCarthy JS; Currie B
AIDS; 2007 Sep; 21(14):1985-6. PubMed ID: 17721111
[No Abstract] [Full Text] [Related]
35. Immune reconstitution syndrome to Strongyloides stercoralis infection.
Taylor CL; Subbarao V; Gayed S; Ustianowski AP
AIDS; 2007 Mar; 21(5):649-50. PubMed ID: 17314529
[No Abstract] [Full Text] [Related]
36. Strongyloides stercoralis infection as a manifestation of immune restoration syndrome.
Kim AC; Lupatkin HC
Clin Infect Dis; 2004 Aug; 39(3):439-40. PubMed ID: 15307018
[No Abstract] [Full Text] [Related]
37. Reemergence of strongyloidiasis, northern Italy.
Abrescia FF; Falda A; Caramaschi G; Scalzini A; Gobbi F; Angheben A; Gobbo M; Schiavon R; Rovere P; Bisoffi Z
Emerg Infect Dis; 2009 Sep; 15(9):1531-3. PubMed ID: 19788836
[No Abstract] [Full Text] [Related]
38. Signaling through Galphai2 protein is required for recruitment of neutrophils for antibody-mediated elimination of larval Strongyloides stercoralis in mice.
Padigel UM; Stein L; Redding K; Lee JJ; Nolan TJ; Schad GA; Birnbaumer L; Abraham D
J Leukoc Biol; 2007 Apr; 81(4):1120-6. PubMed ID: 17242370
[TBL] [Abstract][Full Text] [Related]
39. Strongyloides stercoralis infection as a manifestation of immune restoration syndrome?
Currie BJ; McCarthy JS
Clin Infect Dis; 2005 Feb; 40(4):635. PubMed ID: 15712095
[No Abstract] [Full Text] [Related]
40. Isolation of a cDNA encoding an IgG immunoreactive antigen (zinc finger protein) of Strongyloides stercoralis.
Siddiqui AA; Stanley CS; Berk SL
Parasite; 2001 Jun; 8(2):163-7. PubMed ID: 11474985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
